e

Juozas Grigas1, Ugne Spancerniene2, Martynas Simanavicius3

  • 1Faculty of Veterinary Medicine, Department of Anatomy and Physiology, Lithuanian University of Health Sciences, Tilzes str. 18, Kaunas, Lithuania; Faculty of Veterinary Medicine, Institute of Microbiology and Virology, Lithuanian University of Health Sciences, Tilzes str. 18, Kaunas, Lithuania.

Vaccine
|December 1, 2024
PubMed
概括

重组野生猪肝炎E病毒基因型3 (HEV-3) 囊蛋白显示出作为疫苗候选人的潜力. 接种疫苗的猪产生了显著的免疫反应,这表明它有能力引起对HEV-3的保护.

相关概念视频